Research
Patient age may shape which mutations drive melanoma
The Brief
- Precision medicine aims to match cancer treatment to the genetic changes found in a patient's tumor.
- A new Yale study suggests that for melanoma, the patient's age may be an important clue to consider alongside those genetic changes.
Why it matters
If patient age shapes which mutations drive melanoma, age could become a factor in how tumor genetics are interpreted when choosing treatment, though the source presents this as a suggestion from a single new study.
Who’s affected
- clinicians and researchers in precision oncology
- researchers studying melanoma and cancer genetics
- #melanoma
- #precision medicine
- #cancer genetics
- #patient age
- #oncology
Precision medicine for cancer seeks to match treatment to the genetic changes found in a patient's tumor. A new Yale study suggests that for melanoma there may be an important clue to consider: the patient's age.